## BRO: Brown & Brown, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -0.1% below STRENGTH zone (4.0-10.0%); PEG 4.41 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($77.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Texas Permanent School Fund Corp Lowers Position in Brown & Brown, Inc. $BRO**
- Source: MarketBeat | 20251222T100809 | Neutral | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in Brown & Brown, Inc. (NYSE:BRO) by 67% in the second quarter, selling 34,070 shares and retaining 16,752 shares valued at approximately $1.86 million. This reduction comes despite Brown & Brown exceeding earnings expectations with $1.05 EPS and $1.55 billion in revenue, and increasing its quarterly dividend. The stock currently has an average "Hold" rating from analysts with a target price of $101.00.

**2. Thrivent Financial for Lutherans Cuts Position in Brown & Brown, Inc. $BRO**
- Source: MarketBeat | 20251220T111601 | Neutral | Relevance: 100%
- Thrivent Financial for Lutherans significantly reduced its stake in Brown & Brown, Inc. (NYSE:BRO) by 49.0% in the second quarter, selling 43,462 shares and retaining 45,219 shares valued at $5.01 million. Despite this, Brown & Brown reported strong Q2 earnings, exceeding analyst expectations with EPS of $1.05 and revenue up 35.4% year-over-year, leading to an increase in its quarterly dividend. Analysts currently rate the stock as "Hold" with an average price target of $101.00, while it trades around $80.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | JP Morgan | $91 | $0 | 0% |
| 2025-12-16 | Mizuho | $89 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | JP Morgan | init | Neutral |
| 2025-12-16 | Mizuho | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+4.8%)
- Blackrock Inc.: 6.1% (+2.2%)
- Capital World Invest: 5.1% (+81.1%)
- Principal Financial : 4.5% (+13.4%)
- State Street Corpora: 3.8% (+5.3%)

### Key Risks

1. Valuation stretched: PEG 4.4x requires aggressive growth execution.
2. Long-term trend broken: trading 19.6% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.41 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Revenue growth strong at 23% YoY. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.4B |
| Beta | 0.81 |
| 52W Range | $76.17 - $125.68 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.41 |
| Forward P/E | 17.2 |
| Current P/E | 18.9 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.5% to -0.1% (-1.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.80x), long-term trend not supportive. RSI neutral at 48. Elevated volume (1.7x 20MA), institutional activity likely. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.15% (CS: 45) | Neutral |
| RSI_14 | 48.5 | Neutral |
| MACD Histogram | 0.34 | Bullish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 0.980x | Below |
| vs SMA200 | 0.804x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $80.34
- **Stop Loss:** $77.00 (4.2% risk)
- **Target:** $83.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 269
- **Position Value:** $21,611.46
- **Portfolio %:** 21.61%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-26 (Est: $0.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.93 | $1.05 | +12.9% |
| 2025Q2 | $0.99 | $1.03 | +4.6% |
| 2025Q1 | $1.30 | $1.29 | -0.5% |
| 2024Q4 | $0.77 | $0.86 | +12.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*